High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States
Authors:
- Waleed BrinjikjiWBWaleed Brinjikji
- Christopher P. WoodCWChristopher P. Wood
- Giuseppe LanzinoGLGiuseppe Lanzino
- Harry J. CloftHCHarry J. Cloft
- Sanjay MisraSMSanjay Misra
- David F. KallmesDKDavid F. Kallmes
- Patrick KamathPKPatrick Kamath
- Rajiv K. PruthiRPRajiv K. Pruthi
- Michael J. KrowkaMKMichael J. Krowka
- Vivek N. IyerVIVivek N. Iyer
- 1 September 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 13 (9) , 1505-1511
Abstract
Rationale: There is sparse published literature on the causes and outcomes of hospitalization of patients with hereditary hemorrhagic telangiectasia (HHT). Objectives: To evaluate rates of various complications, comorbidities, and in-hospital outcomes of patients with HHT using a large, multihospital inpatient database. Methods: We identified patients with HHT in the U.S. Nationwide Inpatient Sample between 2000 and 2012. Rates of hemorrhagic, neurological, hepatic, and cardiopulmonary complications among hospitalized patients with HHT were evaluated. We also studied procedure use rates for blood transfusion, endoscopy, and epistaxis treatment. Hospitalization outcomes, including in-hospital mortality, discharge status, charges, and length of stay, were evaluated. Measurements and Main Results: We identified 10,293 patients with HHT. The mean age of the HHT population was 60.7 years. Sixty percent of patients were female. More than 75% of HHT hospitalizations occurred in those older than 50 years of age. Patients with HHT had high rates of bleeding-related complications, including anemia (53.3%), epistaxis (16.2%), and gastrointestinal bleeding (10.8%). Overall, bleeding complications accounted for 62.7% of HHT-related complications. Thirty-eight percent of hospitalized patients with HHT received one or more transfusions of a blood product. Cardiopulmonary complications were present in 41.0% of the cases. Congestive heart failure was the second most common individual complication among patients with HHT, affecting 19.9% of patients. The in-hospital mortality rate was 1.9%. Conclusions: In this large, nationwide study, we found that nearly two-thirds of patients hospitalized with HHT experienced a bleeding-related complication. Nearly 40% of hospitalized patients with HHT required transfusion of blood products. Cardiopulmonary complications, including congestive heart failure, were the second most common complication. The high burden of bleeding-related complications points to a significant unmet clinical need for these patients.Keywords
This publication has 28 references indexed in Scilit:
- Bevacizumab as Rescue Treatment for Severe Recurrent Gastrointestinal Bleeding in Hereditary Hemorrhagic TelangiectasiaJournal of Clinical Gastroenterology, 2013
- Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: A population based studyAmerican Journal of Medical Genetics Part A, 2012
- Iron Deficiency Anemia Related to Hereditary Hemorrhagic Telangiectasia: Response to Treatment With BevacizumabThe American Journal of the Medical Sciences, 2012
- Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesisGenetics in Medicine, 2011
- Osteopetrosis: A Rare Cause of AnemiaHematology Reports, 2011
- Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patientsEuropean Journal of Gastroenterology & Hepatology, 2010
- Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: A single-center studyLiver Transplantation, 2010
- Life expectancy in patients with hereditary haemorrhagic telangiectasiaQJM: An International Journal of Medicine, 2006
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994
- Age‐related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited populationAmerican Journal of Medical Genetics, 1989